Upcoming events on BIONTECH SE |
|
04/06/21 | | Jahr 2020 Ergebnisveröffentlichung (geplant) |
05/18/21 | | Q1 2021 Ergebnisveröffentlichung (geplant) |
08/17/21 | | Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant) |
11/17/21 | | Q3 2021 Ergebnisveröffentlichung (geplant) |
|
Past events on BIONTECH SE |
|
01/11/21 | 07:00pm | | Biotech Showcase Investor Conference - Panel |
01/11/21 | 04:50pm | | JP Morgan Healthcare Conference |
12/02/20 | 12:30pm | | BNT162b2 Update Call |
11/18/20 | 02:00pm | | Wolfe Virtual Healthcare Conference |
|
Upcoming sector events for BIONTECH SE |
|
|
|
Past sector events for BIONTECH SE |
|
|
|
Annual results | 2019 | 2020 (e) |
Sales M € |
Released Forecast Spread | 109 110 -1,6% | 497
|
Operating income (EBITDA) M € |
Released Forecast Spread | -148 -145 -1,9% | -269
|
Operating profit (EBIT) M € |
Released Forecast Spread | -182 -167 -8,7% | -270
|
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -179 -158 -14% | -324
|
Net income M € |
Released Forecast Spread | -179 -157 -14% | -329
|
EPS € |
Released Forecast Spread | -0,85 -0,74 -15% | -1,24
| Announcement Date | 03/31/2020 | |
|
|
Quarterly results | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales M € |
Released Forecast Spread | 28,7 28,5 0,62% | 28,0 30,6 -8,6% | 27,7 24,5 13% | 41,8 41,5 0,58% | 67,5 51,7 30% | 310
| 592
| 1 152
| 1 430
| 2 421
|
Operating income (EBITDA) M € |
Released Forecast Spread | -28,4 -30,1 5,6% | -43,1 -32,7 -32% | -50,7 -55,0 7,8% | -72,1 -50,0 -44% | -178 -72,4 -145% | -78,3
|
|
|
|
|
Operating profit (EBIT) M € |
Released Forecast Spread | -36,9 -38,3 3,8% | -52,9 -40,1 -32% | -59,3 -59,1 -0,38% | -80,9 -74,8 -8,1% | -186 -92,6 -101% | 12,8
| 288
| 674
| 1 155
| 2 707
|
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -30,1 -36,7 18% | -58,5 -36,2 -62% | -53,4 -51,1 -4,5% | -90,5 -61,5 -47% | -208 -73,6 -182% | -75,6
| 293
| 680
| 1 164
| 2 722
|
Net income M € |
Released Forecast Spread | -30,1 -35,3 15% | -58,2 -37,7 -54% | -53,4 -57,2 6,6% | -88,3 -58,9 -50% | -210 -90,0 -133% | 3,29
| 293
| 680
| 1 164
| 2 722
|
EPS € |
Released Forecast Spread | -0,14 -0,16 11% | -0,26 -0,17 -50% | -0,24 -0,25 4,7% | -0,38 -0,32 -20% | -0,88 -0,41 -114% | 0,16
| 1,34
| 2,91
| 4,11
| 8,18
| Announcement Date | 11/14/2019 | 03/31/2020 | 05/12/2020 | 08/11/2020 | 11/10/2020 | | | | | |
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
CureVac strikes COVID-19 vaccine alliance with Bayer |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|